Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: Optical coherence tomography (OCT) noninvasively quantifies retinal nerve fiber layer (RNFL) thickness. Studies show RNFL thinning in multiple sclerosis (MS), and we assessed its association with brain atrophy.
Methods: RNFL thickness was measured in 40 patients with MS and 15 controls. Brain parenchymal fraction (BPF) and partial brain volumes were estimated from cranial MRI scans using SIENA-X. Multiple linear regression modeling assessed the association between OCT and MRI measures of atrophy.
Results: Minimum RNFL thickness and subject age together predict 21% (p = 0.005) of the variance in BPF in all patients with MS and 43% (p = 0.003) of the variance in BPF in the subgroup with relapsing remitting MS (RRMS; n = 20). The partial correlation coefficient between BPF and minimum RNFL thickness, controlling for age, is 0.46 (p = 0.003) in all patients with MS and 0.69 (p = 0.001) in patients with RRMS. These associations are driven by CSF volume but not by gray or white matter volume. There is no significant association of these variables among controls.
Conclusions: In multiple sclerosis (MS), retinal nerve fiber layer thickness is associated with brain parenchymal fraction and CSF volume. These data suggest that quantification of axonal thickness in the retina by optical coherence tomography (OCT) provides concurrent information about MRI brain abnormality in MS. OCT should be examined in longitudinal studies to determine if it could be used as an outcome measure in clinical trials of neuroprotective drugs.
GLOSSARY: BPF = brain parenchymal fraction; EDSS = Expanded Disability Status Scale; KKI = Kennedy Krieger Institute; MNI = Montreal Neurological Institute; MPRAGE = magnetization-prepared rapid gradient echo; MS = multiple sclerosis; OCT = optical coherence tomography; PPMS = primary progressive MS; RNFL = retinal nerve fiber layer; RRMS = relapsing remitting MS; SPMS = secondary progressive MS; TMV = total macular volume.
Much of the permanent disability experienced by patients with multiple sclerosis (MS) is thought to be attributed to axon degeneration secondary to inflammation and demyelination. Conventional MRI techniques are designed to be largely sensitive to inflammation (e.g., T2-weighted lesions) and may not specifically reflect axonal damage. Although quantification of lesions on MRI has been a sensitive tool for monitoring disease activity in MS, it has shown only modest correlation with clinical disability.1,2 Alternatively, whole brain atrophy and T1 black holes have been linked with both disability progression and gross axon loss in MS.1,3–5
Consequently, high-resolution anatomic MRI has been used to derive a measure of whole brain atrophy called the brain parenchymal fraction (BPF), which has been used as a measure of disease progression in patients with MS.1,6–8 This method employs automated normalization and segmentation techniques to compute the volumes of various intracranial compartments and total brain parenchyma.5,9 This metric and similar techniques have been applied to standardized disability measures but with mixed results.7,10–14
Although MRI has become the most widely accepted marker of disease progression, it is both expensive and time consuming. Moreover, in part because of the potential confounding factors of volume loss due to atrophy and volume increase due to inflammation, optimal MRI surrogate measures have yet to be established. Therefore, there remains a need to validate novel methods of monitoring disease progression. Ideal methods are specific for axon damage and can be performed quickly, frequently, conveniently, and inexpensively.
Optical coherence tomography (OCT), a relatively new imaging technique, is a promising and sensitive tool that measures the thickness of the retinal nerve fiber layer (RNFL)15,16 and costs approximately 10 to 15% that of MRI. Recent studies have shown that OCT can detect RNFL thinning, possibly due to axon damage, within the retinas of patients with MS regardless of clinical history of optic neuritis,17–19 suggesting that it may be an effective biomarker of destructive disease.20,21
In this cross-sectional case-control study, we sought to examine whether two OCT measures, RNFL thickness and total macular volume (TMV), are correlated with MRI-derived assessment of brain compartment volumes and BPF, as well as clinical disability.
METHODS
Subjects.
Forty patients with MS (20 relapsing remitting [RRMS], 15 secondary progressive [SPMS], and 5 primary progressive [PPMS]) were recruited from the Johns Hopkins MS clinic. The treating neurologist confirmed the MS diagnosis based on McDonald22 criteria and assigned a clinical disability score based on Kurtzke’s Expanded Disability Status Scale (EDSS).23 There were no selection biases based on history or severity of optic neuritis or MS characteristics. All patients were free from any other known ophthalmologic or neurologic disease. No patient had a history of diabetes or hypertension. Fifteen healthy controls were also recruited from Johns Hopkins and Kennedy Krieger Institute (KKI) as well as from unaffected family members of patients with MS.
The OCT protocol was reviewed by The Johns Hopkins University Institutional Review Board before enrollment began. The MRI protocol was reviewed by The Johns Hopkins University and KKI Institutional Review Boards before enrollment began. Signed, informed consent was obtained from all participants.
Optical coherence tomography.
Retinal imaging was performed using the OCT-3 device with OCT 4.0 software (Carl Zeiss, Meditec, Dublin, CA). Retinal nerve fiber scans were obtained using the “Fast RNFL Thickness” protocol and macular scans were obtained using the “Fast Macular Thickness” protocol.
OCT scanning was performed by two trained technicians at the Johns Hopkins MS clinic. Scans were performed without the use of mydriatic eyedrops. Among patients with pupillary diameters of 5 mm or greater, dilation has been shown to have little impact on OCT values and reproducibility. Previous studies in patients with MS have also been performed without pupillary dilation. All scans analyzed had signal strength score of 6 or above (out of a maximum of 10). Optic disc centering, a precondition for accurate data analysis and reproducibility (for future coregistration), was confirmed by the examining technician at the time of the scan. Average RNFL thickness for each eye (left and right) was recorded. TMV for each eye was also recorded for a subset of individuals (31 patients with MS, 12 controls) because this procedure was added to the protocol after data collection had already begun. The minimum (more abnormal of the two eyes) RNFL thickness and TMV across both eyes were used for the regression analysis. (Similar results to those described below were obtained with average and maximum RNFL thickness and TMV, but the strongest correlations were found with the minimum values.)
Magnetic resonance imaging.
All scans were performed on a 3 Tesla Philips Intera (Philips Medical System, Best, The Netherlands) scanner housed at KKI. Anatomic MRI scans from all subjects were acquired using the following protocol: magnetization-prepared rapid gradient echo (MPRAGE; repetition time 10.4 msec, echo time 6 msec, nominal voxel size = 0.83 × 0.83 × 1.2 mm3, 120 slices) prior to contrast injection.
Brain tissue volumes, normalized for subject head size, were estimated using SIENAX,24 part of FSL.25 SIENAX first extracts brain and skull images from the MPRAGE whole-head volumes.26 The brain-only volume is then spatially normalized to the Montreal Neurological Institute (MNI) avg152 brain volume using affine registration.27,28 The skull-only volume is used to obtain an appropriate scaling factor to normalize the brain to MNI-space to limit normalization due to atrophy. Finally, tissue classification including partial volume estimation29 is performed, from which estimates of gray matter, white matter, and CSF volumes are calculated. The BPF is defined as (gray + white)/(gray + white + CSF), where each component is a partial volume. The coverage of the brain did not always include the vertex, so we excluded brain matter that was located more than 50 mm in the z-direction from the origin of MNI-space.
Statistical analyses.
Statistical analysis was performed by Drs. Cutter and Reich.
Descriptive statistics were calculated for each of the groups (MS overall, MS subtypes, and controls) to characterize our cohort. Multiple linear regression modeling was used, with OCT parameter (minimum RNFL thickness or minimum TMV) and subject age as the independent variables and BPF, normalized brain compartment volume, and EDSS as dependent variables. Partial correlation coefficients between the dependent variables and each of the independent variables, holding the other one fixed, were also calculated. Statistical calculations were performed using Stata 9.0 software (StataCorp LP, College Station, TX). While the hypotheses investigated were specified a priori, the sample size for this study is small and p values are provided as descriptive statistics rather than pure statistical tests of relationships. Significance was determined by a p value of less than 0.05. No adjustments for correlated multiple comparisons were used.
RESULTS
Our study cohort included 40 subjects with MS and 15 controls, all of whom had whole-brain anatomic MRI and OCT scans. The demographics of our study cohort are summarized in table 1. Correlations between brain atrophy (assessed with MRI) and RNFL thickness (assessed with OCT) are also visually striking (figure 1).
Table 1 Demographics and summary statistics
Figure 1 MR images and optical coherence tomography (OCT) results for three patients with multiple sclerosis (MS) depicting the relationship between these two measures
MRI magnetization-prepared rapid gradient echo sequences with the subjects’ corresponding brain parenchymal fraction values are shown above. Retinal nerve fiber layer (RNFL) thickness measures for each subject are shown below for the right (OD) and left (OS) eyes. Circular images below are OCT images. Green quadrants indicate thickness within the 5th to 95th percentile range of the subject’s age group, yellow quadrants fall into the 1st to 5th percentile range, and red quadrant is less than the 1st percentile. The figure shows a spectrum of brain atrophy, from minimal (left) to severe (right). This corresponds to OCT measures that show minimal RNFL thinning on the left (as indicated by green and yellow quadrants and low normal RNFL thickness values) to severe thinning on the right (indicated by more red quadrants and markedly low RNFL thickness values).
Correlations for minimum RNFL thickness and minimum TMV across significant tissue segmentation classifications are presented in table 2 and figure 2. We found that minimum RNFL thickness and age predict a significant amount of the variance (adjusted R-squares of 21% to 23%) in BPF, CSF volume, and EDSS, with absolute partial correlation coefficients for minimum RNFL thickness ranging from 0.35 to 0.47. White matter volume was significantly predicted by age but not by minimum RNFL thickness, and gray matter volume was not associated with these measures. Minimum TMV was not significantly associated with any of the MRI measures or with clinical disability.
Table 2 Characteristics of multiple linear regression model for predicting MRI measures and EDSS from RNFL data
Figure 2 Association between optical coherence tomography and MRI measures or Expanded Disability Status Scale (EDSS)
Patients with multiple sclerosis (MS) are shown on the left and controls on the right. (A) MS brain parenchymal fraction (BPF) vs minimum retinal nerve fiber layer (RNFL) thickness; (B) control BPF vs minimum RNFL thickness; (C) MS CSF volume vs minimum RNFL thickness; (D) control CSF volume vs minimum RNFL thickness; (E) MS BPF vs minimum total macular volume (TMV); (F) control BPF vs minimum TMV; (G) MS EDSS vs minimum RNFL thickness. Regression lines control for age, which for the purposes of this plot is assumed to be held constant at its mean value.
Among controls, there was no significant association between minimum RNFL thickness or TMV and any of the MRI measures, although there was an association between age and gray matter volume that was not found among the patients with MS.
In our subgroup analysis (table 3), significant associations between minimum RNFL thickness were found among patients with RRMS, but not among patients with SPMS. Thus, minimum RNFL thickness could predict up to 43% of the variance in BPF in RRMS. Because the PPMS subgroup contained only five subjects, it was not analyzed separately.
Table 3 Characteristics of the multiple linear regression model for predicting MRI measures from RNFL data by MS subtype
To assess the degree to which multiple linear regression modeling predicts BPF, CSF volume, and EDSS among patients with MS, we calculated the median percent difference between predicted and actual values, as well as the percentage of individuals whose MRI measures and EDSS were predicted within one SD of the actual values. For BPF, median difference was 2.1% (95% predicted within one SD); for CSF volume, 8.8% (95%); and for EDSS, 40% (97%). The larger median difference for EDSS reflects the larger coefficient of variation for that variable (table 1).
DISCUSSION
We report a significant association between RNFL thinning and global brain atrophy (primarily manifested by increasing CSF volume) in a cohort of 40 patients with MS. RNFL thinning also correlates significantly with EDSS. The lack of association in the control group may be an epiphenomenon of a small sample size and the relative youth of the controls we studied: both brain volume loss and RNFL thinning are known to occur in healthy people later in life, and they may be associated with one another. In MS, however, RNFL thickness and age are independently associated with brain atrophy and are not significantly correlated with one another, suggesting that the result is driven at least in part by disease-related pathology. Definitively separating the effects of pathology and normal aging would best be accomplished by longitudinal studies.
Potential explanations for the less than perfect correlations between OCT and MRI volumes may relate to variability in biologic processes and technological limitations of our measures as well as nonlinear relationships between our variables. Biologic processes include 1) brain atrophy is attributed to both myelin as well as axon loss; 2) global brain atrophy may follow years after RNFL thinning caused by an acute episode of optic neuritis; 3) severe damage to only a single eye (with a contralateral healthy eye) may not be representative of severity of damage in the brain; 4) approximately 1/3 to 1/2 of the human brain is devoted to vision and we did not determine whether RNFL thickness correlates with atrophy in that portion of the brain as opposed to overall atrophy. Additionally, the specific mechanism by which RNFL thinning occurs is unknown. Thinning may be partially related to retrobulbar demyelination and loss of phosphorylated neurofilaments leading to decreased axon caliber.21 Further, a cross-sectional relationship may not yield the strongest correlations since brain atrophy may lag behind RNFL changes or vice versa.
On the technical side, although automated segmentation methods reduce user bias, SIENAX imperfectly segments the brain into its components, in part due to subtle differences between signal intensity in brain tissue. This can lead to imperfect estimation of BPF and consequent reduced correlations with OCT measures. Additionally, OCT may itself be an imprecise measure.
Lack of correlation between TMV and BPF may be partially explained by the fact that TMV has been found to change only after many years following disease onset.20,21 Volume loss in the macula has been documented in MS and may be a result of axon loss in the RNFL by retrograde degeneration of retinal ganglion cells. In a cohort of patients with MS with a mean duration of disease of approximately 10 years, TMV may be less informative than in a cohort with a longer history of MS. An alternate explanation may be that TMV measures by OCT are more imprecise than axonal loss measures or have greater variance within a given cohort.
There are a number of reasons that might explain why RNFL thickness correlates with brain atrophy more strongly in RRMS than in SPMS, even when adjusted for age. First, we examined the distributions and the characteristics of the average RNFL within the SPMS cohort. It is possible that there might be a basement effect in the progressive group, where RNFL or brain tissue may have reached its lowest levels, at which the extent of change is minimal. Indeed, the SPMS group was more skewed than the RRMS group.
Another explanation might be related to the phenotype of patients categorized as SPMS. Most patients with SPMS have clinical decline due to cumulative spinal cord disease rather than accumulation of brain disease. Some of these patients might have less cerebral involvement and thus less brain atrophy. In order to identify if any of these hypotheses hold up, a larger cohort and longitudinal studies are necessary, as well as a more detailed analysis of the degree to which each subject’s brain is affected by MS.
This small study presents strong and encouraging data based on a modest sample size with limited numbers of each MS subtype. There remain questions about comparisons between progressive vs relapsing remitting MS. Nonetheless, even with a small number of subjects, the preliminary correlations between OCT and MRI tissue classifications are promising and provide a rationale for future longitudinal studies linking these techniques. Our findings also encourage further assessment of the utility of OCT, which is a rapid and relatively inexpensive test, as a potential outcome measure in clinical trials of neuroreparative and neuroprotective drugs. Overall, these data suggest the possibility that damage to axons in the retina is related to similar changes in the brain and may be able to predict cerebral axon damage. Longitudinal studies and pathologic correlation are necessary to confirm this hypothesis.
ACKNOWLEDGMENT
The authors thank Terri Brawner, Deanna Cettomai, Karen DeBusk, Kathleen Kahl, and Ivana Kusevic for their assistance with this project.
Footnotes
-
Editorial, see page 1562
Supported by The Nancy Davis Center and NMSS TR-3760-A-3.
Disclosure: The authors report no conflicts of interest.
Received March 20, 2007. Accepted in final form April 20, 2007.
REFERENCES
- 1.↵
- 2.
- 3.
De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121(Pt 8):1469–1477.
- 4.
- 5.↵
Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–1695.
- 6.
Rudick RA, Fisher E, Lee JC, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698–1704.
- 7.↵
- 8.
Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121(Pt 1):3–24.
- 9.
- 10.
Liu C, Edwards S, Gong Q, et al. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;66:323–330.
- 11.
De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–1162.
- 12.
- 13.
- 14.
Fisher E, Rudick RA, Cutter G, et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler 2000;6:373–377.
- 15.↵
Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004;45:1716–1724.
- 16.
- 17.↵
- 18.
- 19.
- 20.↵
- 21.↵
- 22.↵
- 23.↵
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.
- 29.↵
Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57.
Letters: Rapid online correspondence
- Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
- Pablo Villoslada, University of Navarra, Pio XII 36. 31008, Pamplona, Spainpvilloslada@unav.es
- Jorge Sepulcre, Jon Toledo, Bartolome Bejarano
Submitted February 05, 2008 - Reply from the authors
- Peter A. Calabresi, Johns Hopkins University, 600 N. Wolfe St, Baltimore, MD 21287Calabresi@jhmi.edu
- Eliza Gordon Lipkin, Betty-Ann Chodkowski, Daniel Reich, Seth Smith, Mathew Pulicken, Elliot Frohman, Laura Balcer, and Gary Cutter
Submitted February 05, 2008 - Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
- Olivier Gout, Department of Neurology, Fondation A de Rothschild, 25 rue Manin 75019 Paris, Franceogout@fo-rothschild.fr
Submitted December 27, 2007 - Reply from the authors/ Gout
- Peter A. Calabresi, Johns Hopkins University, Pathology Buliding Room 627, 600 N. Wolfe St., Baltimore, MD 21287Calabresi@jhmi.edu
Submitted December 27, 2007
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MSJorge Sepulcre, Manuel Murie-Fernandez, Angel Salinas-Alaman et al.Neurology, April 30, 2007 -
Article
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MSMarco Pisa, Simone Guerrieri, Giovanni Di Maggio et al.Neurology, November 15, 2017 -
Drugs and Devices
The application of optical coherence tomography in neurologic diseasesRamiro S. Maldonado, Pradeep Mettu, Mays El-Dairi et al.Neurology: Clinical Practice, September 17, 2015 -
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007